A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.
We sought to determine whether maca, a Peruvian plant, is effective for selective-serotonin reuptake inhibitor (SSRI)-induced sexual dysfunction. We conducted a double-blind, randomized, parallel group dose-finding pilot study comparing a low-dose (1.5 g/day) to a high-dose (3.0 g/day) maca regimen in 20 remitted depressed outpatients (mean age 36+/-13 years; 17 women) with SSRI-induced sexual dysfunction. The Arizona Sexual Experience Scale (ASEX) and the Massachusetts General Hospital Sexual Function Questionnaire (MGH-SFQ) were used to measure sexual dysfunction. Ten subjects completed the study, and 16 subjects (9 on 3.0 g/day; 7 on 1.5 g/day) were eligible for intent-to-treat (ITT) analyses on the basis of having had at least one postbaseline visit. ITT subjects on 3.0 g/day maca had a significant improvement in ASEX (from 22.8+/-3.8 to 16.9+/-6.2; z=-2.20, P=0.028) and in MGH-SFQ scores (from 24.1+/-1.9 to 17.0+/-5.7; z=-2.39, P=0.017), but subjects on 1.5 g/day maca did not. Libido improved significantly (P<0.05) for the ITT and completer groups based on ASEX item #1, but not by dosing groups. Maca was well tolerated. Maca root may alleviate SSRI-induced sexual dysfunction, and there may be a dose-related effect. Maca may also have a beneficial effect on libido.
Dording
Christina M
CM
Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA. cdording@partners.org
Fisher
Lauren
L
Papakostas
George
G
Farabaugh
Amy
A
Sonawalla
Shamsah
S
Fava
Maurizio
M
Mischoulon
David
D
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D029686:Lepidium; D007989:Libido / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010865:Pilot Projects; D010936:Plant Extracts / Q000627:therapeutic use; D018517:Plant Roots; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy
D018687:Antidepressive Agents, Second-Generation; D010936:Plant Extracts; D017367:Selective Serotonin Reuptake Inhibitors
J Sex Marital Ther. 2000 Jan-Mar;26(1):25-40
10693114
Urology. 2000 Apr;55(4):598-602
10736519
J Ethnopharmacol. 2001 May;75(2-3):225-9
11297856
Psychother Psychosom. 2001 Jul-Aug;70(4):221-5
11408842
Asian J Androl. 2001 Sep;3(3):231-3
11561196
Asian J Androl. 2001 Dec;3(4):301-3
11753476
Psychother Psychosom. 2002 May-Jun;71(3):173-6
12021561
Andrologia. 2002 Dec;34(6):367-72
12472620
JAMA. 2003 Jan 1;289(1):56-64
12503977
J Endocrinol. 2003 Jan;176(1):163-8
12525260
Herz. 2003 Jun;28(4):314-24
12825147
Br J Med Psychol. 1959;32(1):50-5
13638508
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
14399272
J Vet Med Sci. 2003 Oct;65(10):1145-6
14600359
J Endocrinol. 2004 Jan;180(1):87-95
14709147
Ann Clin Psychiatry. 2004 Jan-Mar;16(1):15-25
15147109
J Clin Psychiatry. 2005 Jan;66(1):100-6
15669895
Asian J Androl. 2005 Mar;7(1):71-6
15685355
J Ethnopharmacol. 2006 Apr 6;104(3):415-7
16239088
Food Chem Toxicol. 2006 Jul;44(7):1114-22
16510228
J Clin Psychiatry. 2006 Feb;67(2):240-6
16566619
J Clin Psychiatry. 1987 Jul;48(7):268-74
3597327
Br J Soc Clin Psychol. 1967 Dec;6(4):278-96
6080235
Psychother Psychosom. 1998;67(6):328-31
9817955